Lower Urinary Tract Dysfunction Database
This study is currently recruiting participants.
Verified July 2017 by Thomas Kessler, Balgrist University Hospital
Balgrist University Hospital
First Posted: February 10, 2011
Last Update Posted: July 25, 2017
Information provided by (Responsible Party):
Thomas Kessler, Balgrist University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2030|
|Estimated Primary Completion Date:||January 2030 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Leitner L, Guggenbühl-Roy S, Knüpfer SC, Walter M, Schneider MP, Tornic J, Sammer U, Mehnert U, Kessler TM. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned. Eur Urol. 2016 Sep;70(3):522-8. doi: 10.1016/j.eururo.2016.03.052. Epub 2016 Apr 19.